Common MS Treatment Can Bring Longer, Healthier Life
THURSDAY, March 28, 2019 (HealthDay News) — An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer. New research revealed that patients taking a beta interferon drug for more than three years were likely to liveContinue Reading